23361-28-6

Basic information

• Product Name: BOC-VAL-PRO-OH
• Synonyms: BOC-L-VALYL PROLINE;BOC-VAL-PRO-OH;N-BOC-L-VALYL-L-PROLINE;N-tert-Butoxycarbonyl-L-valyl-L-proline;Boc-Val-Pro;L-Proline, N-[(1,1-diMethylethoxy)carbonyl]-L-valyl-;Boc-L-Val-L-Pro-OH;-3-methylbutanoyl)
• CAS NO: 23361-28-6
• Molecular Formula: C₁₅H₂₆N₂O₅
• Molecular Weight: 314.38
• Mol File: 23361-28-6.mol

Chemical Properties

• Melting Point: 137-138 °C
• Boiling Point: 503.2±45.0 °C(Predicted)
• Appearance: /
• Density: 1.171±0.06 g/cm3(Predicted)
• Storage Temp.: -15°C
• PKA: 3.50±0.20(Predicted)
• CAS DataBase Reference: BOC-VAL-PRO-OH(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-VAL-PRO-OH(23361-28-6)
• EPA Substance Registry System: BOC-VAL-PRO-OH(23361-28-6)

Safety Data

• Hazardous Substances Data: 23361-28-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
BOC-VAL-PRO-OH is used as a building block in peptide synthesis for the production of pharmaceuticals. Its Boc protecting group can be selectively removed to reveal the reactive amine group of valine, facilitating the creation of complex peptide sequences and scaffolds.
Used in Agrochemical Industry:
In the agrochemical industry, BOC-VAL-PRO-OH is utilized as a component in the synthesis of bioactive peptides, which can have applications in pest control, plant growth regulation, and other agricultural uses.
Used in Materials Science:
BOC-VAL-PRO-OH is employed in materials science for the development of novel biomaterials and peptide-based materials with specific properties, such as self-assembly, biocompatibility, and stimuli-responsiveness.
Used in Research and Development:
BOC-VAL-PRO-OH serves as a valuable tool in research and development for the exploration of new peptide-based therapeutics, drug delivery systems, and the study of peptide-protein interactions. Its unique structure and reactivity contribute to the advancement of scientific knowledge and the discovery of innovative applications.

Upstream product

• 3392-12-9 Boc-Val-ONSu 
• 147-85-3 L-proline 
• 66866-46-4 C₁₅H₂₇NO₆ 
• 7364-47-8 (S)-trimethylsilyl 1-(trimethylsilyl)pyrrolidine-2-carboxylate 
• 13734-41-3 t-Boc-L-valine 
• 72-18-4 L-valine 
• 5817-26-5 ethyl (2S)-pyrrolidine-2-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 2577-48-2 methyl (2S)-pyrrolidine carboxylate 
• 16652-71-4 benzyl (2S)-2-pyrrolidinecarboxylate hydrochloride 
• 58872-03-0 1--L-valyl>-L-proline phenylmethyl ester 
• 38017-75-3 N-tert-butoxycarbonyl-L-valyl-L-proline methyl ester 

Downstream Products

• 109953-34-6 Boc-Val-Pro-Azala-OBzl 
• 20488-27-1 (S)-1-((S)-2-Amino-3-methyl-butyryl)-pyrrolidine-2-carboxylic acid 

Relevant articles and documents

Inhibition of urease enzyme activity by urea and thiourea derivatives of dipeptides conjugated 2, 3-dichlorophenyl piperazine

Objective: Studies on enzyme inhibition remain an important area of pharmaceutical research since these studies have led to the discoveries of drugs used in a variety of physiological conditions. In search of novel urease enzyme inhibitors, four dipeptide

Structure-activity analysis of peptidic Chlamydia HtrA inhibitors

Chlamydia trachomatis high temperature requirement A (CtHtrA) is a serine protease that performs proteolytic and chaperone functions in pathogenic Chlamydiae; and is seen as a prospective drug target. This study details the strategies employed in optimizi

Stereochemical basis for the anti-chlamydial activity of the phosphonate protease inhibitor JO146

JO146, a mixture of two diastereomers of a peptidic phosphonate inhibitor for Chlamydial HtrA (CtHtrA), has reported activity against Chlamydia species in both human and koala. In this study we isolated the individual diastereomers JO146-D1 and JO146-D2 (

Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes

Novel dipeptide complexes Cu(II)?Val-Pro (1), Zn(II)?Val-Pro (2), Cu(II)?Ala-Pro (3) and Zn(II)?Ala-Pro (4) were synthesized and thoroughly characterized using different spectroscopic techniques including elemental analyses, IR, NMR, ESI-MS and molar conductance measurements. The solution stability study carried out by UV-vis absorption titration over a broad range of pH proved the stability of the complexes in solution. In vitro DNA binding studies of complexes 1-4 carried out employing absorption, fluorescence, circular dichroism and viscometric studies revealed the binding of complexes to DNA via groove binding. UV-vis titrations of 1-4 with mononucleotides of interest viz., 5′-GMP and 5′-TMP were also carried out. The DNA cleavage activity of the complexes 1 and 2 were ascertained by gel electrophoresis assay which revealed that the complexes are good DNA cleavage agents and the cleavage mechanism involved a hydrolytic pathway. Furthermore, in vitro antitumor activity of complex 1 was screened against human cancer cell lines of different histological origin.

NOVEL DIPEPTIDYL PEPTIDASE (DP-IV) COMPOUNDS

The present invention is directed to novel compounds of formula I and pharmaceutically acceptable salts, enantiomers thereof having inhibiting properties of dipeptidyl peptidase IV enzyme (DP-IV inhibitors). The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds along with its composition in the prevention or treatment of diseases associated with DP-IV enzyme. wherein, A is defined as R3-R4 wherein R3 and R4 are together or independently defined as peptides having amino acids ranging from 1 to 10, B is chemical bond between peptide and substituted amine, R1, and R2 are as defined in specification,

Synthesis and antimicrobial activity of 7-Amino cephalosporanic acid derivatives of amino acids and peptides

A novel series of 7-amino cephalosporanic acid derivatives of amino acid and peptides were synthesized by solution phase technique. The synthesized compounds were tested for their biological activities against bacterial and fungal organisms. All the compounds showed potent antifungal activity and most of the compounds have shown moderate antibacterial activities. The structures of the newly synthesized compounds were confirmed by IR, 1H NMR and mass spectral analysis.

Novel C2-C3′ N-peptide linked macrocyclic taxoids. Part 2: Synthesis and biological activities of docetaxel analogues with a peptide side chain at C2 and their macrocyclic derivatives

The synthesis of a series of novel docetaxel analogues possessing a peptide side chain at the C2 position as well as peptide macrocyclic taxoids is described. These compounds were designed to mimic a region of the α-tubulin loop equivalent to the paclitax

N-bromosuccinimide oxidation of dipeptides and their amino acids: Synthesis, kinetics and mechanistic studies

Dipeptides (DP), namely valyl-glycine (Val-Gly), alanyl-proline (Ala-Pro), and valyl-proline (Val-Pro) were synthesized by classical solution phase methods and characterized. The kinetics of oxidation of amino acids (AA) and DP by N-bromosuccinimide (NBS) was studied in the presence of perchlorate ions in acidic medium at 28°C. The reaction was followed spectrophotometrically at λmax = 240 nm. The reactions follow identical kinetics, being first order each in [NBS], [AA], and [DP]. No effect on [H+], reduction product [succinimide], and ionic strength was observed. Effects of varying dielectric constant of the medium and addition of anions such as chloride and perchlorate were studied. Activation parameters have been computed. The oxidation products of the reaction were isolated and characterized. The proposed mechanism is consistent with the experimental results. An apparent correlation was noted between the rate of oxidation of AA and DP.

Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors

The cholecystokinin-8 (CCK-8)-inactivating peptidase is a serine peptidase that has been shown to be a membrane-bound isoform of tripeptidyl peptidase II (EC 3.4.14.10). It cleaves the neurotransmitter CCK-8 sulfate at the Met-Gly bond to give Asp-Tyr(SO

Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics

Structure-based design, chemical synthesis and biochemical testing of a series of novel Smac peptido-mimetics as inhibitors of XIAP protein are described. The most potent compound, 6j, has a binding affinity (Ki value) of 24 nM to XIAP BIR3 pro